These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 32321997)

  • 41. Consideration of disease penetrance in the selection of secondary findings gene-disease pairs: A policy statement of the American College of Medical Genetics and Genomics (ACMG).
    Gordon AS; Lee K; Abul-Husn NS; Amendola LM; Brothers K; Chung WK; Gollob MH; Harrison SM; Hershberger RE; Richards CS; Stewart DR; Martin CL; Miller DT;
    Genet Med; 2024 Jul; 26(7):101142. PubMed ID: 38819344
    [No Abstract]   [Full Text] [Related]  

  • 42. Clinical Utility of Molecular Tumor Board Review for Identification of Possible Germline Pathogenic Variants on Tumor Next-Generation Sequencing Reports.
    Rives TA; Collard J; Li N; Yan D; Dietrich CS; Miller RW; Ueland FR; Pickarski J; Kolesar JM
    JCO Precis Oncol; 2024 Sep; 8():e2400301. PubMed ID: 39259913
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Direct-to-consumer prenatal testing for multigenic or polygenic disorders: a position statement of the American College of Medical Genetics and Genomics (ACMG).
    ACMG Board of Directors
    Genet Med; 2021 Nov; 23(11):2027-2028. PubMed ID: 34183790
    [No Abstract]   [Full Text] [Related]  

  • 44. [Standards for the interpretation of constitutional copy number gain: Recommendation from the American College of Medical Genetics and Genomics (ACMG) and Clinical Genome Resource (ClinGen)].
    Chen X; Shangguan S; Xie H; Liu H; Liu W; An Y; Shen Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Jan; 39(1):1-10. PubMed ID: 34964957
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Frequency of Discordant Variant Classification in the Human Gene Mutation Database: A Comparison of the American College of Medical Genetics and Genomics Guidelines and ClinVar.
    Park KJ; Lee W; Chun S; Min WK
    Lab Med; 2021 May; 52(3):250-259. PubMed ID: 32926152
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Variant Classification Concordance using the ACMG-AMP Variant Interpretation Guidelines across Nine Genomic Implementation Research Studies.
    Amendola LM; Muenzen K; Biesecker LG; Bowling KM; Cooper GM; Dorschner MO; Driscoll C; Foreman AKM; Golden-Grant K; Greally JM; Hindorff L; Kanavy D; Jobanputra V; Johnston JJ; Kenny EE; McNulty S; Murali P; Ou J; Powell BC; Rehm HL; Rolf B; Roman TS; Van Ziffle J; Guha S; Abhyankar A; Crosslin D; Venner E; Yuan B; Zouk H; ; Jarvik GP
    Am J Hum Genet; 2020 Nov; 107(5):932-941. PubMed ID: 33108757
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk categorization for oversight of laboratory-developed tests for inherited conditions: an updated position statement of the American College of Medical Genetics and Genomics (ACMG).
    South ST; McClure M; Astbury C; Bashford MT; Benkendorf J; Esplin ED; Monaghan KG; Oglesbee D; Sutton VR; Watson MS;
    Genet Med; 2020 Jun; 22(6):983-985. PubMed ID: 32127695
    [No Abstract]   [Full Text] [Related]  

  • 48. Updated recommendations for CFTR carrier screening: A position statement of the American College of Medical Genetics and Genomics (ACMG).
    Deignan JL; Gregg AR; Grody WW; Guo MH; Kearney H; Monaghan KG; Raraigh KS; Taylor J; Zepeda-Mendoza CJ; Ziats C;
    Genet Med; 2023 Aug; 25(8):100867. PubMed ID: 37310422
    [No Abstract]   [Full Text] [Related]  

  • 49. Venous thromboembolism laboratory testing (factor V Leiden and factor II c.*97G>A), 2018 update: a technical standard of the American College of Medical Genetics and Genomics (ACMG).
    Zhang S; Taylor AK; Huang X; Luo B; Spector EB; Fang P; Richards CS;
    Genet Med; 2018 Dec; 20(12):1489-1498. PubMed ID: 30297698
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ACMG response to Nussbaum et al. letter on ACMG policy statement: the use of secondary findings recommendations for general population screening: a policy statement of the ACMG.
    American College of Medical Genetics and Genomics Board of Directors
    Genet Med; 2019 Dec; 21(12):2838-2839. PubMed ID: 31239558
    [No Abstract]   [Full Text] [Related]  

  • 51. Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium.
    Amendola LM; Jarvik GP; Leo MC; McLaughlin HM; Akkari Y; Amaral MD; Berg JS; Biswas S; Bowling KM; Conlin LK; Cooper GM; Dorschner MO; Dulik MC; Ghazani AA; Ghosh R; Green RC; Hart R; Horton C; Johnston JJ; Lebo MS; Milosavljevic A; Ou J; Pak CM; Patel RY; Punj S; Richards CS; Salama J; Strande NT; Yang Y; Plon SE; Biesecker LG; Rehm HL
    Am J Hum Genet; 2016 Jun; 98(6):1067-1076. PubMed ID: 27181684
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
    Green RC; Berg JS; Grody WW; Kalia SS; Korf BR; Martin CL; McGuire AL; Nussbaum RL; O'Daniel JM; Ormond KE; Rehm HL; Watson MS; Williams MS; Biesecker LG;
    Genet Med; 2013 Jul; 15(7):565-74. PubMed ID: 23788249
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Germline sequencing for presumed germline pathogenic variants via tumor-only comprehensive genomic profiling.
    Kondo T; Yamamoto Y; Fukuyama K; Kanai M; Yamada A; Matsubara J; Quy PN; Yoshioka M; Yamada T; Minamiguchi S; Matsumoto S; Kosugi S; Muto M
    Int J Clin Oncol; 2022 Aug; 27(8):1256-1263. PubMed ID: 35567649
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incidental germline variants in 1000 advanced cancers on a prospective somatic genomic profiling protocol.
    Meric-Bernstam F; Brusco L; Daniels M; Wathoo C; Bailey AM; Strong L; Shaw K; Lu K; Qi Y; Zhao H; Lara-Guerra H; Litton J; Arun B; Eterovic AK; Aytac U; Routbort M; Subbiah V; Janku F; Davies MA; Kopetz S; Mendelsohn J; Mills GB; Chen K
    Ann Oncol; 2016 May; 27(5):795-800. PubMed ID: 26787237
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cancer Predisposition Sequencing Reporter (CPSR): A flexible variant report engine for high-throughput germline screening in cancer.
    Nakken S; Saveliev V; Hofmann O; Møller P; Myklebost O; Hovig E
    Int J Cancer; 2021 Dec; 149(11):1955-1960. PubMed ID: 34310709
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diagnostic gene sequencing panels: from design to report-a technical standard of the American College of Medical Genetics and Genomics (ACMG).
    Bean LJH; Funke B; Carlston CM; Gannon JL; Kantarci S; Krock BL; Zhang S; Bayrak-Toydemir P;
    Genet Med; 2020 Mar; 22(3):453-461. PubMed ID: 31732716
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Secondary genomic findings in the 2020 China Neonatal Genomes Project participants.
    Xiao H; Zhang JT; Dong XR; Lu YL; Wu BB; Wang HJ; Zhao ZY; Yang L; Zhou WH
    World J Pediatr; 2022 Oct; 18(10):687-694. PubMed ID: 35727495
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics.
    Gregg AR; Skotko BG; Benkendorf JL; Monaghan KG; Bajaj K; Best RG; Klugman S; Watson MS
    Genet Med; 2016 Oct; 18(10):1056-65. PubMed ID: 27467454
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical tumor sequencing: an incidental casualty of the American College of Medical Genetics and Genomics recommendations for reporting of incidental findings.
    Parsons DW; Roy A; Plon SE; Roychowdhury S; Chinnaiyan AM
    J Clin Oncol; 2014 Jul; 32(21):2203-5. PubMed ID: 24958819
    [No Abstract]   [Full Text] [Related]  

  • 60. High-Throughput Genetic Testing in ALS: The Challenging Path of Variant Classification Considering the ACMG Guidelines.
    Lattante S; Marangi G; Doronzio PN; Conte A; Bisogni G; Zollino M; Sabatelli M
    Genes (Basel); 2020 Sep; 11(10):. PubMed ID: 32987860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.